Efficacy and Safety of Dapagliflozin for Type 2 Diabetes Mellitus Patients With a History of Cardiovascular Disease

被引：0
|
作者：
Leiter, Lawrence A.
Cefalu, William T.
Debruin, Tjerk W.
Gausenilsson, Ingrid
Sugg, Jennifer
Parikh, Shamik J.
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1114-P
引用
收藏
页码：A287 / A287
页数：1
相关论文
共 50 条
  • [1] Two-year efficacy and safety of dapagliflozin for patients with type 2 diabetes mellitus and a history of cardiovascular disease
    Gause-Nilsson, I.
    DeBruin, T. W.
    Sugg, J.
    Parikh, S. J.
    Johnsson, E.
    Leiter, L. A.
    [J]. DIABETOLOGIA, 2014, 57 : S325 - S325
  • [2] Efficacy and safety of dapagliflozin treatment for type 2 diabetes mellitus patients with comorbid cardiovascular disease and hypertension
    Cefalu, W.
    Leiter, L.
    De Bruin, T.
    Gause-Nilsson, I.
    Sugg, J.
    Parikh, S.
    [J]. DIABETOLOGIA, 2012, 55 : S305 - S305
  • [3] Dapagliflozin treatment for type 2 diabetes mellitus patients with a history of cardiovascular disease
    Leiter, L.
    Cefalu, W.
    DeBruin, T.
    Gause-Nilsson, I.
    Sugg, J.
    Parikh, S.
    [J]. DIABETOLOGIA, 2012, 55 : S310 - S311
  • [4] Efficacy and Safety of Dapagliflozin as Monotherapy for Type 2 Diabetes Mellitus in Japanese Patients
    Kaku, Kohei
    Inoue, Satoshi
    Matsuoka, Osamu
    Kiyosue, Arihiro
    Azuma, Haruna
    Hayashi, Nobuya
    Tokudome, Takuto
    Langkilde, Anna Maria
    Parikh, Shamik
    [J]. DIABETES, 2012, 61 : A260 - A260
  • [5] Long-term maintenance of efficacy of dapagliflozin in patients with type 2 diabetes mellitus and cardiovascular disease
    Leiter, L. A.
    Cefalu, W. T.
    de Bruin, T. W. A.
    Xu, J.
    Parikh, S.
    Johnsson, E.
    Gause-Nilsson, I.
    [J]. DIABETES OBESITY & METABOLISM, 2016, 18 (08): : 766 - 774
  • [6] Long-term Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes, Cardiovascular Disease, and Hypertension
    Cefalu, William T.
    Gause-Nilsson, Ingrid Ami
    De Bruin, Tjerk W. A.
    Sugg, Jennifer E.
    Parikh, Shamik J.
    Johnsson, Eva
    [J]. DIABETES, 2014, 63 : A286 - A286
  • [7] Comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in India
    Varshney, Amit
    Rawat, Ramakant
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2023, 69 (08):
  • [8] Efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus and concomitant heart failure
    Kosiborod, M.
    Gause-Nilsson, I.
    Sonesson, C.
    Johnsson, E.
    [J]. DIABETOLOGIA, 2015, 58 : S368 - S368
  • [9] The efficacy and safety of dapagliflozin in women and men with type 2 diabetes mellitus
    Michelle L. O’Donoghue
    Eri T. Kato
    Ofri Mosenzon
    Sabina A. Murphy
    Avivit Cahn
    Marisol Herrera
    Tsvetalina Tankova
    Alena Šmahelová
    Piera Merlini
    Ingrid Gause-Nilsson
    Anna Maria Langkilde
    Darren K. McGuire
    John P. H. Wilding
    Larry A. Leiter
    Deepak L. Bhatt
    Itamar Raz
    Marc S. Sabatine
    Stephen D. Wiviott
    [J]. Diabetologia, 2021, 64 : 1226 - 1234
  • [10] The efficacy and safety of dapagliflozin in women and men with type 2 diabetes mellitus
    O'Donoghue, Michelle L.
    Kato, Eri T.
    Mosenzon, Ofri
    Murphy, Sabina A.
    Cahn, Avivit
    Herrera, Marisol
    Tankova, Tsvetalina
    Smahelova, Alena
    Merlini, Piera
    Gause-Nilsson, Ingrid
    Langkilde, Anna Maria
    McGuire, Darren K.
    Wilding, John P. H.
    Leiter, Larry A.
    Bhatt, Deepak L.
    Raz, Itamar
    Sabatine, Marc S.
    Wiviott, Stephen D.
    [J]. DIABETOLOGIA, 2021, 64 (06) : 1226 - 1234
12345